Citation tools
"Safety and Efficacy of SBI-087, a Subcutaneous Agent for B Cell Depletion, in Patients with Active Rheumatoid Arthritis: Results from a Phase II Randomized, Double-blind, Placebo-controlled Study." The Journal of Rheumatology
43.12
(2016):
2094-2100.
Web. 19 April. 2024.